09/09/2025 Why I Am Bullish on the PDUFA Decision for Incyte’s Opzelura Label Expansion Incyte’s Opzelura faces a key FDA PDUFA decision on Sept 19, 2025 for pediatric atopic dermatitis. Here’s why approval could boost $INCY stock. #pdufa read here 31/08/2025 Biogens Alzheimer drug Leqembi Iqlik got approved, my move now The FDA approved a subcutaneous version of Leqembi #pdufa read here ← newer older →
09/09/2025 Why I Am Bullish on the PDUFA Decision for Incyte’s Opzelura Label Expansion Incyte’s Opzelura faces a key FDA PDUFA decision on Sept 19, 2025 for pediatric atopic dermatitis. Here’s why approval could boost $INCY stock. #pdufa read here
31/08/2025 Biogens Alzheimer drug Leqembi Iqlik got approved, my move now The FDA approved a subcutaneous version of Leqembi #pdufa read here